Therillume
Founded 2021
About Therillume
Therillume is a clinical-stage neuro-oncology therapeutics company that focuses on glioblastoma and Neurofibromatosis Type 1 and 2 (“NF1 and NF2”). The company uses its precise gene-editing platform to identify and validate and expedite high-quality candidates through clinical development. Therillume was founded in 2021 and is located in Eagan, Minnesota.
Company Facts
- Founded: 2021
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: therillume.com
- Phone: 16125947207
Social Profiles
Canonical: https://fsome.com/organization/therillume-8300062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.